Pharma Business Week articles from May 2003

Pharma Business Week archives from May 2003

Tumor cells in blood may indicate more aggressive cancer.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- If patients with breast cancer have tumor cells circulating in the blood, they may have a more dangerous form of the disease, according to a study by researchers at the University of Texas M.D. Anderson...

Patient factors, site of care influence antibiotic prescription.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Patient characteristics and the location of care were both factors that influenced the choice of antibiotic prescribed for patients with community-acquired pneumonia (CAP), according to a new study. ...

New set of tools helps pharmaceutical companies improve efficiency.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- BioInnovators, Inc., in conjunction with JRS Pharma LP (formerly the excipient business of Penwest) - have developed the concept of Excipio Economics. This new set of tools is designed to help...

Despite WHI, HERS II studies, HRT market will experience robust growth.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., finds that despite negative impact of the Women's Health Initiative (WHI) and the Heart and Estrogen/Progestin Replacement Study (HERS II), the hormone replacement therapy...

Half of Internet pharmacies not licensed.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- PharmacyChecker.com, a new website that evaluates online pharmacies and compares their prices, finds that only 50% of the pharmacy sites it has evaluated dispense through a licensed pharmacy. The...

FDA approves new Rapamune labeling likely to improve kidney functioning.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has announced the approval of revised labeling for Rapamune (sirolimus) that will allow new kidney transplant patients at low to moderate immunologic risk of...

Three new products launched for detecting genetic mutations.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Nanogen, Inc., (NGEN), a provider of molecular diagnostics, announced the availability of three new products for the detection of certain genetic mutations often associated with Alzheimer disease,...

Antiviral drug discovery alliance signed.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals, Inc., and Entomed SA, have entered into a collaboration to jointly discover and develop novel antiviral drugs. The partnership will focus on the discovery of new lead...

Continued growth forecasted in minimally invasive CABG technologies.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Medtech Insight announced the publication of a comprehensive new report by Health Research International entitled "U.S. Opportunities in Surgical Coronary Revascularization." This meticulously...

Approval granted to market generic equivalent to Paxil in Spain.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Bentley Pharmaceuticals, Inc., (BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced that the Spanish Ministry...

Generics generate brand management opportunities.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- "Brand Erosion by Generics" is a newly released report from EP Publications, a service of WWMR, Inc., examining five of the most notable cases in which branded pharmaceutical shares have been eroded by...

Pharma companies tackle disease management.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Top pharmaceutical companies are developing disease management programs at an increased rate, according to a report from pharmaceutical intelligence firm Cutting Edge Information. Disease...

Pharmaceutical blockbuster launches: Companies increase DTC marketing.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies spent about $2.6 billion on mass-media ads for prescription drugs in 2002, according to new research by pharmaceutical intelligence firm Cutting Edge Information. Through...

Vision CI provides early warning of competition for launched pharmaceuticals.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Newport announced the release of Vision CI, its next-generation competitive intelligence system targeted at pharmaceutical companies seeking to protect global revenues and market share by identifying...

Celgene to dominate the multiple myeloma drug market through 2011.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that Celgene will dominate the multiple myeloma (MM) drug market through 2011. Celgene's Thalomid and, later, its analogues will revolutionize the second-line...

Lloyd E. Flanders, PhD, named senior vice president of development.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Neurocrine Biosciences, Inc., (NBIX) announced the appointment of Lloyd E. Flanders, PhD. to the position of senior vice president of development. Flanders brings over 31 years of biotech and...

Study finds parents have difficulty in administering children's medication.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- FLAVORx, a medicine-flavoring system used by pharmacists to safely add flavors to liquid medicines to improve taste and increase compliance, announced survey findings conducted of parents of pediatric...

De Souza named president, CEO.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Archemix Corp., the biopharmaceutical company developing aptamer therapeutics, announced the appointment of Errol De Souza as president and CEO. De Souza, most recently president and CEO of Synaptic...

Glogowski joins research company as VP, Market Research.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on physicians' prescribing behavior, announced that Martin S. Glogowski, PhD, has joined the company as VP,...

New CEO named at pharmaceutical company.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Chugai Pharma USA, LLC (CPUSA), a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd., announced the appointment of David J. Mazzo, a veteran executive with more than 20 years of international...

New president, CEO named at biopharmaceutical company.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- AviGenics, Inc., announced that Yashwant Deo has been named the company's president and CEO. He has also been elected a member of the board of directors. Deo succeeds Carl Marhaver, who has been named...

Elan Corp. concludes ribozyme-based oncology joint venture.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Ribozyme Pharmaceuticals, Inc., (RZYM) announced that it has concluded its collaboration with Elan Corp., plc, relating to the Medizyme Pharmaceuticals, Ltd., joint venture. Under the terms of this...

Pharmaceutical company receives NASDAQ notice.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc., (SPPI) announced that the company received a NASDAQ staff determination indicating that the company is not in compliance with the stockholder's equity requirement set...

Recruitment of clinical sites complete for phase III INACTINE study.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc., (VITX) ("Vitex") announced it had completed the recruitment of the clinical trial study sites for the company's chronic transfusion study. These sites, which are staffed by...

Use of photopheresis marks growth of therapeutic apheresis market.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- The growing uptake of photopheresis in new and off-label indications is the major factor driving growth of the therapeutic apheresis market in the United States. New analysis from Frost & Sullivan,...

Sanwa enters stem cell biology partnership and financing.
May 5, 2003... 2003 MAY 5 - (NewsRx.com & NewsRx.net) -- VistaGen Therapeutics, Inc., announced the signing of a strategic research partnership with Sanwa Kagaku Kenkyusho Co., Ltd., an international pharmaceutical company headquartered in Nagoya, Japan. ...

FDA approves first treatment.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved the first treatment for patients with Fabry Disease, a serious metabolic genetic disorder affecting approximately 1 in 40,000 males. While...

Antipsychotic drug risperidone reduces tics in children and adults.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- A study by Yale researchers suggests that the atypical antipsychotic drug risperidone reduces tic symptoms in children and adults with Tourette syndrome (TS). "These results suggest that...

Integracide A exhibits inhibitory activity against HIV-1 integrase.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Integracide A exhibits inhibitory activity against HIV-1 integrase, scientists in New Jersey report. According to a study from the United States, "HIV-1 integrase is a critical enzyme in the...

Patient assistance programs expanded, drug giant announces.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said its Patient Assistance Programs will be expanded to provide additional medicines following the successful close of its acquisition of Pharmacia. Pfizer will continue to operate...

Marketing rights acquired to almotriptan malate tablets.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Ortho-McNeil Pharmaceutical, Inc. announced it will acquire the U.S. sales and marketing rights to Axert (almotriptan malate) Tablets, pursuant to a licensing agreement with the drug's innovator...

Cardiothoracic surgery challenging interventional cardiology.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- With the emergence of multiple technologies and techniques, and their efficient integration into healthcare systems, cardiothoracic surgery is on the verge of rivaling interventional cardiology...

Investor ask pharma company to lower AIDS drug prices.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- The mammoth California Public Employees Retirement System (CalPERS) - which holds nearly $760 million in GlaxoSmithKline (GSK) stock - voted unanimously to send a letter to Glaxo CEO Jean-Paul Garnier...

Management is key in getting drugs to market faster.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- According to a recent survey, pharmaceutical manufacturers took an average 8 years to bring a novel drug to market and industry associations estimate the high-end cost of a novel drug is $800 million....

AIDS groups to pressure big pharma to lower cost of Fuzeon.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- A coalition of AIDS groups from across California, the U.S., Italy, and other parts of the world launched a campaign urging pharmaceutical maker, F. Hoffmann-La Roche to lower the price of its new...

Company's first quarter 2003 results impacted by heart and cancer drugs.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) has reported consolidated financial results for the quarter ended March 31, 2003. Revenue for the quarter was $81.7 million, compared with $68.6...

Drug addiction research, development company raises $700,000.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Catalyst Pharmaceutical Partners announced completion of a capital financing of $700,000 in new equity. This round of financing was primarily with accredited private investors in the United...

Investment allows for development of cancer vaccine.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Biovest International, Inc., announced that it has entered into an investment agreement with Accentia, Inc., one of the Hopkins Capital Group portfolio companies. Accentia is a privately held...

Dramatic expansion predicted for rheumatoid arthritis drug market.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts dramatic expansion for the rheumatoid arthritis (RA) drug market. According to a new Pharmacor study, "Rheumatoid Arthritis," the launch of new biologic agents, such...

Analysis says pharma companies must increase local "thought leader" use.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies continue to pursue national and regional "thought leaders" to influence local markets when community opinion leaders would be more appropriate, according to a new study by...

Pharmaceutical sales reps adapt to new HIPAA guidelines.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- The new Health Insurance Portability and Accountability Act (HIPAA) code, which went into effect in April 2003 to protect patient privacy, could reduce physician access for sales reps by 25%, according...

Acquisition of injectable treatment for severe pain announced.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- aaiPharma (NASDAQ:AAII) has acquired exclusive rights to a parenterally administered methadone product, formerly branded as Dolophine Hydrochloride Injection, from Roxane Laboratories, Inc. ...

Mekalanos named to scientific advisory board.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- ActivBiotics, Inc., a privately held pharmaceutical company, announced that John J. Mekalanos has joined its scientific advisory board. Mekalanos is the Adele H. Lehman professor of Microbiology...

Record 47% generic drug utilization at Express Scripts in first quarter.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Generic drug utilization reached an all-time high of 47% of all prescriptions processed by Express Scripts during the first quarter of 2003, up from 45.9% in the fourth quarter of 2002 and 43% in the...

Company's new focus prompts name change.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Ribozyme Pharmaceuticals, Inc. (NASDAQ:RZYM) has changed its name to Sirna Therapeutics, Inc. The new focus of the company is the research and development of RNA interference (RNAi) based...

Development and commercialization rights for intranasal apomorphine reacquired.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc. (NASDAQ:NSTK), which focuses on nasal drug delivery, has reacquired all development and commercialization rights for intranasal apomorphine from Pharmacia following the...

Economical source provided for biopharmaceutical, injectable medications.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- An increasing number of Americans depend on specialty and self-injectable medications for treatment of their chronic, sometimes life-threatening, illnesses, and conditions. From 1990 to 2000, the...

Company receives NASDAQ panel decision.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Valentis, Inc. (NASDAQ:VLTS) received notification from the NASDAQ Listing Qualifications Panel on April 15, 2003, that its common stock will continue to be listed on The NASDAQ SmallCap Market via an...

Therapeutic vaccines firm raises UKP15 million in international funding round.
May 12, 2003... 2003 MAY 12 - (NewsRx.com & NewsRx.net) -- Oxxon Pharmaccines Ltd., a biotechnology company developing innovative immunotherapeutics, specifically therapeutic vaccines (pharmaccines), has raised UKP15 million pounds ($23 million) in a private...

Results of pleconaril study reported at conference.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- A presentation at the recent Conference on Antiviral Research in Savannah, Georgia, summarized results of a study that was conducted from August to October 2001 and designed to evaluate the...

Nizatidine does not prevent long-term weight gain caused by olanzapine.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Results from a double-blind, placebo-controlled trial indicate that nizatidine does not prevent long-term weight gain caused by olanzapine therapy. "Weight gain is associated with treatment with...

Study supports value of resistance tests to guide use of newer HIV drugs.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc., (VLGC) announced that results of a recent study support the utility of its proprietary drug resistance assays to guide HIV/AIDS treatment with regimens containing the recently marketed...

Company reports positive results from evaluation of new solid tumor treatment.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Northwest Biotherapeutics, Inc., (NWBT) announced positive findings from a recently completed preclinical mouse tumor evaluation of its new product candidate, DCVax-Direct Adjuvant Cancer Therapy,...

Pharmaceutical pricing structures revealed in new document.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The Academy of Managed Care Pharmacy (AMCP) has published an online document on its Web site detailing the complex and confusing pricing structure that governs pharmaceutical distribution practices....

Phase III study for Bromfenac commenced.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced that the company has filed an Investigational New Drug application with the U.S. Food & Drug Administration (FDA) to begin a phase III study of bromfenac....

Reseller agreements signed for life sciences databases.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- BioZak InfoBase, Inc., a provider of marketing intelligence information on the life science industry, announced agreements with PharmCast and Research and Markets, LTD, who will serve as resellers of...

PhRMA adopts voluntary program to report counterfeit drugs to FDA.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The Pharmaceutical Research and Manufacturers of America (PhRMA) announced that it has adopted a voluntary program to report counterfeit drugs to the U.S. Food and Drug Administration (FDA). "This...

Cancer drug maker reports loss of $0.23 per share; SARS vaccine update.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC) announced financial results for the first quarter ended March 31, 2003. GenVec reported a net loss of $5.2 million or ($0.23) per share, a 19% reduction compared to a net loss...

Pharmaceutical company reports 27% increase in revenues for first quarter.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) reported revenues of $5.4 million for the quarter ended March 31, 2003, a 27% increase over revenues of $4.2 million for the quarter ended March 31, 2002. ...

Reorganization plan announced by biotech company.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Essential Therapeutics, Inc., (ETRX) announced its intention to work with a majority of the holders of its Series B Convertible Preferred Stock. They will jointly develop a plan of reorganization...

Lannett announces Levothyroxine marketing and distribution agreement.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Lannett Co., Inc,. (LCI) a manufacturer of generic pharmaceuticals, announced the addition of Levothyroxine Sodium Tablets to its product line. The manufacturer of the product, Jerome Stevens...

Company reports fiscal 2003 third quarter results.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Lannett Co., Inc. (LCI), a manufacturer of generic pharmaceuticals, announced its unaudited results of operations for the quarter and 9 months ended March 31, 2003. The company's results of...

2002 Pharma-biotech alliances rise to highest rate since 2000.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- As the pharmaceutical industry continues consolidating, companies will increasingly turn to biotechnology firms to energize their pipelines and remain competitive, according to a study by...

Biotechs well ahead of big pharma in MAP kinase-based therapeutics.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Decision Resources announced that several biotechnology companies are at the forefront of the quest to bring mitogen-activated protein (MAP) kinase pathway-based therapeutics to market, and will do so...

Expansion in Pittsburgh reflects success greenhouse initiatives.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The Pittsburgh Life Sciences Greenhouse (PLSG), a partnership to put the region's life sciences industry on a fast track for growth, announced that Crystalplex Corporation will be the first PLSG...

Pharmaceutical brand teams spend 46% of marketing budgets during launch.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Companies that back products with optimal resources at the right time push drugs to commercial success, according to a report by pharmaceutical intelligence firm Cutting Edge Information. The...

Pharmaceutical sales forces to expand 22%, new study says.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Top pharmaceutical companies plan to increase sales headcounts by an average of 22% over the next 18-24 months - a fact that proves the era of sales force expansion will continue, according to a new...

Company announces that all resolutions were passed at annual meeting.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Novuspharma, SpA, (NOV) a biopharmaceutical company focused on cancer, announced that all the resolutions were passed at the company's annual general meeting. At the meeting, it was announced that...

Foundation appoints clinical advisory board.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The ALS Therapy Development Foundation (ALS-TDF) announced the appointment of its clinical advisory board (CAB), composed of researchers of amyotrophic lateral sclerosis (ALS), also called Lou Gehrig...

Rexall Sundown names Steven H. Brenia SVP of marketing.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- Steven H. Brenia has been named senior vice president of marketing, Rexall Sundown, Inc., according to Ralph Denisco, CEO. In this position, he will be responsible for all marketing activities of...

Company provides first quarter 2003 performance report.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- As Pfizer begins the integration of Pharmacia, the company reported strong first-quarter financial results, with revenues up 10%, reported diluted earnings per share (EPS) up 145% to $0.76, and...

E-health's influence continues to grow as use of the Internet increases.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The third report in the "Vital Signs" series, based on two Harris Interactive surveys conducted for, and published by, The Boston Consulting Group, reveals that in the United States e-health is growing...

Pharmaceutical sales: Sales force budgets approach $1 billion.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- The industry average for field force budgets hovers near $875 million, and top-spending organizations dedicate more than $1 billion to their sales efforts, according to a recently released study by the...

Additional Remodulin patents granted.
May 19, 2003... 2003 MAY 19 - (NewsRx.com & NewsRx.net) -- United Therapeutics Corp. (UTHR) announced that the U.S. Patent and Trademark Office has issued two patents that broaden United Therapeutics' patent protection for its lead drug Remodulin. U.S....

Results of investigational muscarinic antagonist reported.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Yamanouchi Pharma America, Inc., a subsidiary of Yamanouchi Pharmaceutical Co., Ltd., a pharmaceutical company in Japan, announced results from three placebo-controlled clinical trials, showing that...

Patients who miss a few days of medication at increased risk for hospitalization.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Failure to take medication consistently - a common problem among people with schizophrenia - can have serious consequences, including a significantly increased risk of hospitalization, according to new...

Pharma firm donates supplies for war relief; announces West Nile alliance.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) has sent cases of hospital, pharmaceutical, and nutritional products valued at $2.1 million to AmeriCares, a not-for-profit humanitarian aid organization, to aid thousands of...

Research: Satisfaction, erectile quality improved with Levitra.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- New clinical findings on men's perceptions of their sexual experiences showed that men with erectile dysfunction (ED) who were taking 10 mg or 20 mg of the oral investigational drug Levitra (vardenafil...

Patient compliance with angiotensin II antagonist treatment is good.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- According to an article from Merck & Co. Inc., Worldwide Human Health Outcomes Research in Current Hypertension Reports, patients tend to comply with angiotensin II antagonist treatment for their...

Phase III data on trospium offers promise for OAB.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Data presented at the American Urological Association (AUA) annual meeting showed that trospium, a new developmental drug for overactive bladder (OAB), significantly reduced the symptoms of OAB while...

Roche chooses ESM solution.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Ariba, Inc., (ARBA), an enterprise spend management (ESM) solutions provider, announced that Roche is using Ariba spend management solutions. With the addition of Roche, Ariba says it can now count...

Study shows barriers to the diagnosis and treatment of ADHD.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Fear of social stigma, lack of knowledge, and fear of over-diagnosis probably inhibit many African-American and Hispanic parents from seeking diagnosis and treatment of Attention Deficit Hyperactivity...

License granted to market Biocoral in Canada.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Biocoral, Inc., (BCRA) announced that it has recently received, from Health Canada, Therapeutic Products directorate, a license to market its Biocoral, product in Canada. Health Canada,...

Zealand Pharma enters collaboration for ZP123.
May 26, 2003... 2003 MAY 26 - (NewsRx.com & NewsRx.net) -- Zealand Pharma, A/S, has entered into a development and license agreement with Wyeth (WYE). Under the terms of the agreement, the two companies will codevelop ZP123, Zealand's novel drug candidate...